Abingdon Health (LON:ABDX) Trading 2.6% Higher – Time to Buy?

Abingdon Health Plc (LON:ABDX)’s stock price was up 2.6% during mid-day trading on Thursday . The stock traded as high as GBX 11 and last traded at GBX 10.77. Approximately 315,994 shares traded hands during trading, an increase of 18% from the average session volume of 267,036 shares. The stock had previously closed at GBX 10.50.

Abingdon Health Stock Up 2.6%

The stock has a fifty day moving average price of GBX 10.74 and a 200 day moving average price of GBX 9.18. The company has a debt-to-equity ratio of 15.05, a current ratio of 1.91 and a quick ratio of 1.96. The stock has a market capitalization of £27.04 million, a P/E ratio of -13.30 and a beta of 0.16.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.